GREECE'S AGENDA TO COMBAT CANCER

Mary Bussell, manager health policy and insight, Economist Impact, lead, The Vaccine Ecosystem Initiative 

Mary Bussell Founder

Stella Kyriakides, commissioner for health and food safety, European Commission (recorded message)

Stella Kyriakides Commissioner for health and food safety

● Cancer-related health policy developments in Greece
● HeSMO reflections of 2022
● The role of patients in cancer policy shaping
● Securing resilient healthcare systems to meet oncology patient needs

Thanos Plevris, minister of health, Greece
Zenia Saridaki – Zoras, medical oncologist, director, 1st Oncology Department, Metropolitan Hospital, president of the BoD, Hellenic Society of Medical Oncology (HeSMO)
Nikos Dedes, chair, Greek Patients' Association
Cyril Schiever, senior vice-president & president of Mid Europe region, MSD

Thanos Plevris Minister of migration and asylum

Zenia Saridaki – Zoras Medical oncologist and president of the board

Nikos Dedes Chair

Cyril Schiever President of mid-Europe Region

● Vaccines in Europe: where do we stand?
● Monitoring cancer inequalities
● Cancer inequalities in clinical practice
● Cancer inequalities and patient experience

Laurent Louette, director public affairs and country liaison, Vaccines Europe
Caroline Berchet, health economist, OECD Health Division (via connection)
Ioannis Boukovinas, medical oncologist, head of BIOCLINIC Oncology Unit, Thessaloniki
Merel Hennink, patient advocate

Commentator:
Evangelia Razis, medical oncologist, director 3rd Oncology Dept., Hygeia Hospital, director, Contemporary Oncology Team

Laurent Louette Director public affairs and country liaison

Caroline Berchet Health economist

Ioannis Boukovinas Medical oncologist, Head

Merel Hennink Patient advocate

Evangelia Razis Medical oncologist, director 3rd Oncology dept., Hygeia Hospital, director

● Policy actions towards a national action plan
● Key elements of a national cancer plan
● Investing in innovation
● The role of oncology nursing in cancer management
● Creating patient-centric cancer strategy

Mina Gaga, alternate minister of health, Greece
Anastasios Boutis, consultant medical oncologist, 1st Oncology Department, "Theagenio" Anticancer Hospital of Thessaloniki
Kostas Athanasakis, assistant professor in health economics and health technology assessment, Department of Public Health Policy, University of West Attica
Dimitrios Papageorgiou, assistant professor, University of Peloponnese, head, Nurse Oncology Unit, Euroclinic Athens, president, Hellenic Oncology Nursing Society
George Kapetanakis, president, Hellenic Cancer Federation (ELLOK) 

Commentator:
Athina Christopoulou, medical oncologist, head, Department of Internal Medicine, Division of Clinical Oncology, St. Andrew’s General Hospital of Patra

Mina Gaga Alternate minister of health

Anastasios Boutis Consultant medical oncologist, Director, "Theagenio" Anticancer Hospital of Thessaloniki, Treasurer

Kostas Athanasakis Assistant professor in health economics and health technology assessment

Dimitrios Papageorgiou Assistant professor, University of Peloponnese, President

George Kapetanakis President

Athina Christopoulou Medical oncologist, head, Department of Internal Medicine, Division of Clinical Oncology, St. Andrew’s General Hospital of Patra, Special secretary of the BoD

● The progress of the national public health strategy in Greece
● New EU screening recommendations
● The potential of preventing cancer through vaccination 
● The role of health literacy for patient well-being

Irene Agapidaki, secretary-general of public health, Ministry of Health, Greece (via connection)
Amanda Psyrri, professor of medical oncology, National Kapodistrian University of Athens, chair, Nomination Committee European Society of Medical Oncology, chairman of medicine, Attikon University Hospital (recorded message)
Ilias Athanasiadis, medical oncologist, director of oncology clinic, Mitera Hospital
Kristine Sørensen, founder, Global Health Literacy Academy, president, International Health Literacy Association

Commentator:
Nikolaos Tsoukalas, medical oncologist, deputy director, Oncology Department, 401 General Military Hospital, vice-president of the BoD, Hellenic Society of Medical Oncology (HESMO)

Amanda Psyrri Professor of medical oncology, National Kapodistrian University of Athens, Chairman of internal medicine

Ilias Athanasiadis Μedical oncologist, director of oncology clinic

Kristine Sørensen Founder, Global Health Literacy Academy, President

Nikolaos Tsoukalas Director, oncology dept., Veterans Hospital 417 NIMTS, General secretary of the board

● The importance of biomarker testing in clinical practice
● The application of precision medicine in oncology
● The value of biomarker testing in patient lives
● Imaging biomarkers

Flora Zagouri, professor of medical oncology, National and Kapodistrian University of Athens, Greece
Constantine Stratakis, president, EDIMO, chief scientific officer, ELPEN, director (Res. A'), Human Genetics & Precision Medicine, Foundation for Research and Technology - Hellas (FORTH)
Paraskevi Michalopoulou, president, Alma Zois 

Commentator:
Anastasios Gaitanis, research scientist, professor level, clinical and preclinical PET/CT, Biomedical Research Foundation of the Academy of Athens

Flora Zagouri Professor of medical oncology

Constantine Stratakis Director, EDIMO & human genetics and precision medicine, Institute for Molecular Biology & Biotechnology (IMBB)

Paraskevi Michalopoulou President, Hellenic Association of Women with Breast Cancer, Vice-president

Anastasios Gaitanis Research scientist, professor level, clinical and preclinical PET/CT

●  Clinical trials in oncology: Perspectives in Greece
●  AI in cancer research
● Towards a cancer mission in Horizon Europe
● The footprint of pharmaceutical industry in cancer research

Konstantinos Syrigos, professor of medicine & oncology,  head, 3rd Department of Medicine, Athens School of Medicine, National & Kapodistrian University of Athens,  chairman of BoD,  Hellenic Association of Lung Cancer (HeALC)
Michalis Karamouzis, medical oncologist, professor, Medical School, National and Kapodistrian University of Athens Athens (via connection)
Christine Chomienne, professor emeritus, University Paris Cité, vice-chair, Horizon Europe Cancer Mission Board
Vanessa Witte, executive director and oncology medical affairs strategy lead, EMEAC, MSD

Commentator:
Emmanouil Saloustros, associate professor of oncology, University of Thessaly, member of the BoD, Hellenic Society of Medical Oncology (HeSMO) (via connection)

Konstantinos Syrigos Professor of medicine and oncology, National and Kapodistrian University of Athens; Chairman of the board

Michalis Karamouzis Medical Oncologist, Professor, Medical School

Christine Chomienne Professor emeritus, University Paris Cité, Vice-chair

Vanessa Witte Executive director and oncology medical affairs strategy lead, EMEAC

Emmanouil Saloustros Associate professor of oncology, University of Thessaly, Member of the BoD

● The value of early identification and treatment of cancer patients
● National and EU developments in assessment of cancer therapies
● The importance of patient reported outcomes (PROs) in cancer management
● Life after cancer
● Ensuring affordable access to cancer innovation

Sofia Agelaki, professor of medical oncology, Faculty of Medicine, University of Crete, 
medical oncologist, University General Hospital of Heraklion, Crete 
Flora Bacopoulou, Head, Health Technology Assessment (HTA) Committee, associate professor of pediatrics – adolescent medicine, National and Kapodistrian University of Athens
Dafni Kaitelidou, president, National Agency for Quality Assurance in Health (ODIPY)
Mark Lawler, associate pro-vice chancellor, professor of digital health and chair in translational cancer genomics, Queen's University Belfast (via connection)
Nandia Gogozotou, Non-executive president, EOPYY, president, Drug Price Negotiation Committee

Commentator:
Michalis Liontos, medical oncologist, assistant professor, department of clinical therapeutics, oncology unit, National and Kapodistrian University of Athens

Sofia Agelaki Professor of medical oncology

Flora Bacopoulou Head, HTA Committee, Hellenic Ministry of Health, Associate professor of pediatrics – adolescent medicine

Dafni Kaitelidou Professor, Department of Nursing, NKUA, Director, Center for Health Services Management and Evaluation, President

Mark Lawler Associate pro-vice chancellor, professor of digital health and chair in translational cancer genomics

Nandia Gogozotou Non-executive president, EOPYY, President

Michalis Liontos Medical oncologist, Assistant professor of oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Member of the BoD

● The impact of EHDS in cancer management
● The value of digital tools in clinical practice
● The application of home care services in oncology patients

Federico Milani, deputy head of the data policy and innovation unit, DG CONNECT, European Commission (via connection)
Michail Nikolaou, medical oncologist, 1st medical  Oncology Department, General Anticancer - Oncology Hospital of Athens “Saint Savvas”
Olga Balaoura, president of the board & CEO, General Anticancer - Oncology Hospital of Athens “Saint Savvas”

Commentator:
Paris Kosmidis, head of the second Medical Oncology Department, Hygeia Hospital, former president, ESMO

Federico Milani Deputy head

Michail Nikolaou Medical oncologist, “Saint Savvas” General Anticancer Oncology Hospital of Athens, Vice-president of the board

Olga Balaoura Chief executive

Paris Kosmidis Ηead of the second Medical Oncology Department, Hygeia Hospital, Former president

● Cancer priorities of the Hellenic Society of Medical Oncology in 2023

Zenia Saridaki – Zoras, medical oncologist, director, 1st Oncology Department, Metropolitan Hospital, president of the BoD, Hellenic Society of Medical Oncology (HeSMO)

Mary Bussell, associate, Economist Impact, lead, The Vaccine Ecosystem Initiative

Zenia Saridaki – Zoras Medical oncologist and president of the board

Mary Bussell Founder